Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism
This study is currently recruiting participants.
Study NCT00198107   Information provided by National Institute of Mental Health (NIMH)
First Received: September 12, 2005   Last Updated: March 25, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Autistic Disorder
More general conditions related to this trial
Child Development Disorders, Pervasive
Mental Disorders
Mental Disorders Diagnosed in Childhood
Interventions listed in this trial
Aripiprazole
Placebo
D-cycloserine
fMRI
Additional drug interventions recognized in this trial
Cycloserine
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Antibiotics, Antitubercular
Antimetabolites
Antipsychotic Agents
Antitubercular Agents
Central Nervous System Agents
Central Nervous System Depressants
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Renal Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services